LJ GP Nominee Limited Company accounts

LJ GP NOMINEE LIMITED - Company Information

false false false false false false true false false true false false false false false false false No description of principal activity 2018-07-01 Sage Accounts Production Advanced 2019 - FRS102_2014 xbrli:pure xbrli:shares iso4217:GBP 09625306 2018-07-01 2019-06-30 09625306 2019-06-30 09625306 2018-06-30 09625306 bus:RegisteredOffice 2018-07-01 2019-06-30 09625306 bus:Director1 2018-07-01 2019-06-30 09625306 bus:Director2 2018-07-01 2019-06-30 09625306 bus:Director3 2018-07-01 2019-06-30 09625306 core:ShareCapital 2019-06-30 09625306 core:ShareCapital 2018-06-30 09625306 bus:SmallEntities 2018-07-01 2019-06-30 09625306 bus:AuditExempt-NoAccountantsReport 2018-07-01 2019-06-30 09625306 bus:FullAccounts 2018-07-01 2019-06-30 09625306 bus:SmallCompaniesRegimeForAccounts 2018-07-01 2019-06-30 09625306 bus:PrivateLimitedCompanyLtd 2018-07-01 2019-06-30

COMPANY REGISTRATION NUMBER: 09625306

LJ GP Nominee Limited

Unaudited Financial Statements

30 June 2019

LJ GP Nominee Limited

Financial Statements

Year ended 30 June 2019

Contents	Page

Directors' report	1

Statement of financial position	2

Notes to the financial statements	3

LJ GP Nominee Limited

Directors' Report

Year ended 30 June 2019

The directors present their report and the unaudited financial statements of the company for the year ended 30 June 2019 .

The company has been dormant as defined in section 1169 of the Companies Act 2006 throughout the year and preceding financial year. It is anticipated that the company will remain dormant for the foreseeable future.

Directors

The directors who served the company during the year were as follows:

Mr A De Meyer
Mr J Elkington
Mr A Williams

Small company provisions

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

This report was approved by the board of directors on 30 April 2020 and signed on behalf of the board by:

Mr A De Meyer

Director

Registered office:

10 Old Burlington Street

London

W1S 3AG

LJ GP Nominee Limited

Statement of Financial Position

30 June 2019

	2019		2018
Note	£	£	£

Current assets

Cash at bank and in hand	1		1
	----		----
Net current assets		1	1
		----	----
Total assets less current liabilities		1	1
		----	----

Capital and reserves

Called up share capital	1	1
	----	----
Shareholders funds	1	1
	----	----

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

The company did not trade during the current year or prior year and has not made either a profit or loss.

For the year ending 30 June 2019 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

These financial statements were approved by the board of directors and authorised for issue on 30 April 2020 , and are signed on behalf of the board by:

Mr A De Meyer

Director

Company registration number: 09625306

LJ GP Nominee Limited

Notes to the Financial Statements

Year ended 30 June 2019

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 10 Old Burlington Street, London, W1S 3AG.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Income statement

The company is dormant as defined by section 1169 of the Companies Act 2006. The company received no income and incurred no expenditure during the current year or prior year and therefore no income statement is presented within these financial statements. There have been no movements in shareholders funds during the current year or prior year.

Financial instruments

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability. Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity. Compound instruments Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

4. Related party transactions

The company was under the control of Alvarium Investments Limited throughout the current year. Alvarium Investments Limited is the shareholder. No transactions with related parties were undertaken such as are required to be disclosed under FRS102.